" class="no-js "lang="en-US"> RayCare In Clinical Use With CyberKnife at Swiss Medical Network in Switzerland - Medtech Alert
Friday, April 12, 2024

RayCare In Clinical Use With CyberKnife at Swiss Medical Network in Switzerland

RaySearch Laboratories AB (publ) announces that La Clinique Générale-Beaulieu, a part of Swiss Medical Network in Switzerland, is the first center in the world to treat a patient using the Accuray CyberKnife® radiation treatment delivery system with RaySearch treatment planning system RayStation®* and oncology information system RayCare®*.

The first treatment was successfully carried out on May 4, 2022. The clinic is equipped with RaySearch’s RayCare 5A and RayStation 11A and the CyberKnife M6TM Robotic Radiosurgery System is connected to Accuray’s iDMS® Data Management System.

La Clinique Générale-Beaulieu has been using RayCare and RayStation for more than a year. Step by step the systems have been implemented and integrated into daily operations and today the clinic manages all aspects of the treatment, for all their machines, through RaySearch software. This gives a comprehensive picture of the patients’ treatments while taking advantage of RayCare’s efficiency for all patients.

Swiss Medical Network is one of Switzerland’s two largest groups of private clinics. Within the network all types of cancers are treated, using cutting-edge technology and complex treatment methods. In 2019, as the first hospital in the world, Swiss Medical Network signed a multi-system, multi-clinic agreement for the purchase of Accuray radiation therapy delivery systems as well as RaySearch’s treatment planning system and oncology information system.

Professor Oscar Matzinger, medical director of radiation oncology at Swiss Medical Network, says: “We are happy to announce that we have successfully treated our first patient using RayStation and RayCare with a CyberKnife machine. In partnership with RaySearch and Accuray we are now closing the loop regarding treatment delivery, using only RaySearch software for both CyberKnife and Radixact machines.”

Johan Löf, founder and CEO, RaySearch, says: “We are very pleased to hear that the first treatment with CyberKnife and RayCare has been successfully carried out at this world-class center. It is an important proof of concept that a clinic can use RayCare as the sole oncology information system together with Accuray machines. This makes the achievement of significant value not only for our mutual collaboration with Swiss Medical Network but also for potential collaborations with other clinics around the world with a similar machine set-up and, above all, for patients in need of radiotherapy treatment.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more